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Abstract
Background: Preterm birth (PTB) is a major cause of infant morbidity and mortality, but the relationship between
comorbidity and PTB by clinical subtype and severity of gestational age remains poorly understood. We evaluated
associations between maternal comorbidities and PTB by clinical subtype and gestational age.
Methods: We conducted a retrospective cohort study of 1,329,737 singleton births delivered in hospitals in the
province of Québec, Canada, 1989-2006. PTB was classified by clinical subtype (medically indicated, preterm
premature rupture of membranes (PPROM), spontaneous preterm labour) and gestational age (< 28, 28-31, 32-36
completed weeks). Odds ratios (OR) of PTB by clinical subtype for systemic and localized maternal comorbidities
were estimated using polytomous logistic regression, adjusting for maternal age, grand multiparity, and period.
Attributable fractions were calculated.
Results: PTB rates were higher among mothers with comorbidity (10.9%) compared to those without comorbidity
(4.7%). Several comorbidities were associated with greater odds of medically indicated PTB compared with no
comorbidity, but only comorbidities localized to the reproductive system were associated with spontaneous PTB.
Drug dependence and mental disorders were strongly associated with PPROM and spontaneous PTBs across all
gestational ages (OR > 2.0). At the population level, several major comorbidities (placental abruption,
chorioamnionitis, oliogohydramnios, structural abnormality, cervical incompetence) were key contributors to all
clinical subtypes of PTB, especially at < 32 weeks. Major systemic comorbidities (preeclampsia, anemia) were key
contributors to PPROM and medically indicated PTBs.
Conclusions: The relationship between comorbidity and clinical subtypes of PTB depends on gestational age.
Prevention of PPROM and spontaneous PTB may benefit from greater attention to preeclampsia, anemia and
comorbidities localized to the reproductive system.
Background
Preterm birth (PTB) is a major cause of mortality and
morbidity throughout life and rates are increasing in
many countries [1-3]. The determinants of PTB remain
poorly understood [1]. Evidence suggests that maternal
comorbidities are associated with PTB, especially pree-
clampsia, infection, uterine anomalies, and placental
complications [1,4-6]. Many studies have not considered
PTB by clinical subtype [5,6]. Associations with comor-
bidities are particularly unclear for preterm premature
rupture of membranes (PPROM) and spontaneous pre-
term labour with intact membranes [1], the two subtypes
of spontaneous PTB that are most challenging to prevent
[7,8]. While medically indicated PTB has clearly been
linked with ischemic placental disease [4,9], relationships
remain to be established for spontaneous PTB which
appears to be more closely linked with infectious pro-
cesses [1,8,10,11]. However, studies are conflicting [7]
and often limited by misclassification of gestational age
or PTB clinical subtype [4,6,12].
Fewer studies have examined the relationships between
comorbidity and PTB clinical subtype at different gesta-
tional ages, despite evidence suggesting that factors trig-
gering PTB may differ depending on gestational age
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bleeding, cervical incompetence and chorioamnionitis
may be more strongly associated with PTB at < 32 weeks
of gestation compared with later PTB, though clinical
subtype was not differentiated [6]. Research of PTB
before 28 or 34 weeks has found associations with pree-
clampsia, placental abruption, chorioamnionitis, oligohy-
dramnios, cervical insufficiency, and fetal factors [14,15],
but again without evaluating clinical subtype. Informa-
tion on how maternal comorbidities influence PTB rates
at early gestational ages is needed, especially since PTBs
below 32 weeks are responsible for nearly 50% of long
term neurologic morbidity and 60% of perinatal mortal-
ity, despite accounting for only 1-2% of live births [2].
This gap in the literature needs to be addressed to
better understand which maternal comorbidities to tar-
get for prevention of PTB at different gestational ages,
especially PPROM and spontaneous preterm labour
which are difficult to prevent [7,8]. This study sought to
evaluate the associations between major maternal
comorbidities and PTB by clinical subtype and gesta-
tional age.
Methods
Data and variables
This study was based on a retrospective cohort of all
births in Québec hospitals from 1989 to 2006 (N =
1,351,211). Nearly 100% of infants in Québec are deliv-
ered in hospitals [16]. Maternal birth records were
extracted from hospital discharge abstracts using the
ninth revision of International Classification of Disease
(ICD) codes for delivery (650, and 640-676 with 1 or 2 in
the fifth position) recorded as the principal diagnosis or
one of fifteen secondary diagnoses [16]. Hospital transfers
(N = 21) and foreign visitors with no provincial health
insurance number (N = 15,399) were excluded. We also
excluded multiple births and stillbirths (646.0, 651, 652.6,
656.4, 678.1, V271-V277) and pregnancy terminations
(779.6) for which mechanisms driving PTB may differ
(N = 21,471).
Births at < 37 completed weeks of gestation were
defined as PTBs [1]. Gestational age estimates in Québec
are ultrasound-based which may be more accurate than
estimates based on recall of date of last menstruation
[13]. Recall-based measures are a common limitation of
population-based research [12]. Clinical subtypes of PTB
included medically indicated, PPROM, and spontaneous
preterm labour [1,9,17-19]. Spontaneous PPROM was
identified using ICD-9 codes 658.2-658.4 among births <
37 weeks. Medically indicated PTB cases that were not
secondary to PPROM were identified using procedure
codes for labour induction (855, 850.1, 851.9) and cesar-
ean delivery (860-862, 868, 869) [16]. The remaining
PTBs were designated spontaneous preterm labour with
intact membranes, hereafter denoted spontaneous PTB.
PTB subtypes were further categorized as extreme (< 28
weeks), very (28-31 weeks), and moderate (32-36 weeks)
[13,17]. Four births with missing data on gestational age
were excluded, leaving 1,329,737 cases in the final analy-
sis cohort. Births at extremely early gestational ages
(under 20 weeks, n = 565; 0.04%) were not excluded, as
they may represent true cases of PTB [7] (and sensitivity
analyses excluding these cases yielded similar findings).
Maternal comorbidities based on the ICD-9 [20] were
classified in two broad categories to facilitate data classi-
fication (systemic comorbidities vs. comorbidities loca-
lized to the reproductive tract). Common comorbidities
recorded as the principal or secondary diagnosis were
grouped into sub-categories within these two broad cate-
gories. Systemic comorbidities representing a more gen-
eralised maternal disease process included hypertension
(preeclampsia/eclampsia, pre-existing, gestational, unspe-
cified), cardiovascular disease, diabetes (pre-existing,
gestational), edema/renal disease, genitourinary infection,
general infection, thyroid disease, anemia, drug depen-
dence, mental disorders, and other comorbidity. Loca-
lized comorbidities included hemorrhage (placental
abruption, placenta previa, other), chorioamnionitis,
amniotic sac disorders (polyhydramnios, oligohydram-
nios, unspecified), cervical incompetence, structural
abnormality, previous cesarean delivery, and fetal factors
(anomaly, other). ICD-9 codes are provided (Additional
file 1). Comorbidity variables were expressed categori-
cally for hypertension, diabetes, hemorrhage, amniotic
sac disorders, and fetal factors, and dichotomously for
the remaining conditions.
Covariates included maternal age (< 20, 20-24, 25-29,
30-34, 35-39, ≥ 40 years), grand multiparity (ICD-9
659.4; ≥ 5 versus < 5 previous live births) [21], and period
(1989-1993, 1994-1997, 1998-2001, 2002-2006).
Statistical analysis
Descriptive statistics (n, %) were computed. Logistic
regression was used to estimate odds ratios (OR) and
95% confidence intervals (CI) for comorbidity indicators
and overall preterm birth (without considering clinical
subtype) in models that were unadjusted and adjusted for
maternal age, grand multiparity and period. Polytomous
logistic (or multinomial) regression [22,23] was used to
evaluate adjusted associations between each comorbidity
and PTB subtype (medically indicated, PPROM, sponta-
neous) for each gestational age category in models using
term births (≥ 37 weeks) as the referent [13]. Polytomous
models containing one indicator of comorbidity at a time
were run using the glogit option of the LOGISTIC proce-
dure in SAS [23]. To evaluate the extent to which PTB
rates were attributable to each comorbidity, population
attributable fractions were computed with the formula
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lyses were performed with SAS version 9.2 (Statistical
Analysis System, Cary, North Carolina) and SPSS version
17.0 statistical software. This study conformed to the
2010 Tri-Council Policy Statement for ethical conduct of
research involving humans in Canada. Approval was
waived by the research ethics committee of the Univer-
sity of Montreal Hospital Centre.
Results
Overall, 6.2% of births were preterm, of which 28.7%
were medically indicated, 30.7% PPROM, and 40.6%
spontaneous. Over 5% of PTBs occurred at < 28 weeks,
7.3% at 28-31 weeks, and 87.2% at 32-36 weeks. The
majority of PTBs at < 28 weeks were spontaneous
(44.2%), followed by PPROM (29.3%) and medically indi-
cated (26.5%). A similar pattern was observed for PTBs at
32-36 weeks, among which 41.5% were spontaneous,
30.7% PPROM, and 27.8% medically indicated. In con-
trast, PTBs at 28-31 weeks were more frequently medi-
cally indicated (40.6%) than PPROM (31.8%) or
spontaneous (27.6%). The proportion of PTB was greater
for mothers with localized (10.9%) and systemic comor-
bidities (8.7%), compared to those without comorbidity
(4.7%, Table 1). Systemic and localized comorbidities
were present in 34.1% and 31.8% of births, respectively
(data not in table). Among mothers with systemic comor-
bidities, medically indicated PTBs (4.1%) were more fre-
quent than PPROM (2.2%) or spontaneous PTBs (2.4%);
a similar pattern was observed for mothers with localized
comorbidities. Among mothers with no comorbidity,
however, spontaneous PTBs (2.4%) were more common
(though just as frequent as in mothers with systemic
comorbidities). Spontaneous PTBs accounted for the lar-
gest proportion (> 41%) of births that were severely (< 28
weeks) and moderately (32-36 weeks) preterm, but medi-
cally indicated PTBs (40.6%) accounted for the largest
proportion of very PTBs (28-31 weeks).
PTB was more frequent among mothers with pree-
clampsia/eclampsia (24.1%), drug dependence (21.4%),
and edema/renal disease (17.0%) (Table 2, systemic
comorbidity). Among mothers with drug dependence,
spontaneous PTB was more frequent (9.8%) than
PPROM (6.2%) or medically indicated PTB (5.5%), espe-
cially at 32-36 weeks (8.5%). For all other causes of sys-
temic comorbidity, medically indicated PTB was more
frequent than PPROM and spontaneous PTB. Gesta-
tional diabetes and mental disorders were exceptions as
the frequency of PTB was similar across clinical
subtypes.
PTB was very common among mothers with major
localized co-morbidities, especially cervical incompe-
tence (47.4%), fetal anomalies (43.2%), placenta previa
(35.2%) and placental abruption (31.9%) (Table 2, loca-
lized comorbidity). For cervical incompetence, sponta-
neous PTB was more frequent (21.5%) than PPROM
(14.7%) or medically indicated PTB (11.2%). For other
causes of localized comorbidity, medically indicated PTB
was more frequent than PPROM or spontaneous PTB.
An exception was chorioamnionitis, for which PPROM
Table 1 Preterm birth (PTB) rates by maternal characteristic, Québec, 1989-2006
All PTB % Medically indicated % PPROM* % Spontaneous
† % Total births
Maternal age
< 20 years 8.4 1.9 2.1 4.3 56,647
20-24 years 6.7 1.7 2.0 3.0 260,848
25-29 years 5.8 1.6 1.8 2.4 487,831
30-34 years 5.7 1.8 1.8 2.2 373,906
35-39 years 6.9 2.4 2.2 2.3 130,525
≥ 40 years 8.6 3.5 2.6 2.5 19,979
Grand multiparity 6.1 1.7 1.7 2.7 6,010
Period
1989-1993 5.9 1.6 1.7 2.7 454,300
1994-1997 6.3 1.8 1.9 2.6 321,884
1998-2001 6.4 1.9 2.1 2.5 276,252
2002-2006 6.5 2.1 2.1 2.3 277,301
Comorbidity
Systemic 8.7 4.1 2.2 2.4 323,433
Localized 10.9 4.9 2.9 3.0 241,580
No 4.7 0.5 1.7 2.4 839,539
Total 6.2 1.8 1.9 2.5 1,329,737
* Preterm premature rupture of membranes
† Spontaneous preterm labour before 37 gestational weeks with intact membranes
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Page 3 of 10Table 2 Preterm birth (PTB) rates according to maternal systemic/localized comorbidity and gestational age (weeks) at delivery, and the proportionso f
comorbidity among PTBs
All PTB % Medically indicated
%
PPROM*
%
Spontaneous
†
%
Comorbidity
‡ % Total births
< 37 < 28 28-31 32-36 < 37 < 28 28-31 32-36 < 37 < 28 28-31 32-36 < 37 < 37
Systemic comorbidity
Hypertension
Preeclampsia/eclampsia 24.1 1.0 3.3 16.3 20.6 0 0.1 1.2 1.3 0 0.1 2.1 2.2 8.7 29,915
Pre-existing 11.0 0.2 0.7 5.8 6.7 0.1 0.1 1.9 2.1 0.1 0.1 1.9 2.1 0.8 7,439
Gestational 6.1 0.1 0.2 3.2 3.5 0 0.1 1.1 1.2 0 0 1.3 1.4 1.0 11,380
Cardiovascular disease 10.3 0.2 0.6 4.4 5.3 0.2 0.3 2.1 2.6 0.2 0 2.2 2.5 0.6 4,434
Diabetes
Pre-existing 13.1 0.1 0.6 5.5 6.1 0.1 0.5 3.1 3.7 0.1 0.3 2.9 3.2 2.7 16,938
Gestational 8.4 0.1 0.2 2.6 2.8 0.1 0.2 2.4 2.7 0 0.1 2.8 2.9 5.1 50,313
Edema/renal disease 17.0 0.6 1.9 9.9 12.4 0.1 0.2 1.6 2.0 0.3 0.1 2.3 2.6 0.8 3,977
Genitourinary infection 8.4 0.2 0.5 2.7 3.3 0.2 0.4 2.0 2.6 0.2 0.1 2.1 2.5 3.2 31,477
General infection 10.0 0.2 0.4 3.2 3.8 0.3 0.4 2.2 2.9 0.3 0.2 2.7 3.2 1.9 16,024
Thyroid disease 8.9 0.2 0.4 3.0 3.7 0.2 0.3 2.3 2.8 0.2 0.2 2.2 2.5 1.4 12,687
Anemia 6.9 0.2 0.4 2.3 2.9 0.2 0.2 1.5 2.0 0.2 0.1 1.7 2.0 11.7 140,410
Drug dependence 21.4 0.2 0.8 4.5 5.5 0.6 0.7 5.0 6.2 0.6 0.7 8.5 9.8 3.9 3,229
Mental disorders 13.2 0.4 0.5 3.7 4.5 0.3 0.6 3.2 4.1 0.4 0.3 3.9 4.6 9.3 7,688
Localized comorbidity
Hemorrhage
Placental abruption 31.9 1.3 2.4 9.9 13.6 1.3 1.6 3.6 6.6 2.3 1.8 7.6 11.7 8.6 22,278
Placenta previa 35.2 0.8 2.9 26.3 30.0 0.9 0.5 2.4 3.8 0.3 0.2 1.1 1.5 2.3 5,265
Chorioamnionitis 11.0 0.3 0.3 1.4 1.9 1.2 1.2 3.1 5.5 1.0 0.5 2.1 3.6 7.3 55,133
Amniotic sac
Polyhydramnios 12.5 0.3 0.8 4.9 6.0 0.2 0.3 2.0 2.5 0.3 0.5 3.4 4.1 1.3 8,861
Oligohydramnios 20.6 0.8 1.8 10.4 13.0 1.1 1.4 3.2 5.7 0.3 0.2 1.5 1.9 3.8 15,293
Cervical incompetence 47.4 3.4 1.5 6.4 11.2 6.3 2.7 5.7 14.7 11.3 2.1 8.1 21.5 1.5 2,570
Structural abnormality 13.0 0.6 1.1 5.1 6.7 0.4 0.6 3.2 4.2 0.4 0.2 1.5 2.1 3.1 19,515
Previous cesarean delivery 5.8 0.1 0.2 2.9 3.3 0.1 0.1 1.3 1.5 0.1 0.1 0.9 1.0 8.4 118,608
Fetal anomaly 43.2 8.2 1.9 11.7 21.9 0.2 0.6 2.4 3.2 12 0.6 5.5 18.1 0.5 935
Total 6.2 0.1 0.2 1.5 1.8 0.1 0.1 1.7 1.9 0.1 0.1 2.2 2.5 1,329,737
* Preterm premature rupture of membranes
† Spontaneous preterm labour before 37 weeks of gestation with intact membranes
‡ Proportion of comorbidity among PTBs overall
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0was more frequent (5.5%) than medically indicated
(1.9%) or spontaneous PTB (3.6%).
Localized comorbidities as a whole were more strongly
associated with overall PTB (OR 2.27, 95% CI 2.24-2.31)
than systemic comorbidities (OR 1.66, 95% CI 1.63-1.68)
(Table 3). Both systemic and localized comorbidities
were associated with statistically significant four-fold
greater odds of medically indicated PTB. Associations
were modest for PPROM but nonetheless statistically sig-
nificant. In contrast, spontaneous PTB was only asso-
c i a t e dw i t hl o c a l i z e d( b u tn o ts y s t e m i c )c o m o r b i d i t i e s .
Associations were robust to adjustments for covariates.
Almost all categories of systemic and localized comor-
bidity were associated with greater odds of overall PTB
(data not shown). For systemic comorbidities, associa-
tions with overall PTB were highest for preeclampsia/
eclampsia (OR 5.1, 95% CI 5.0-5.3), drug dependence
(OR 3.9, 95% CI 3.5-4.2), and edema/renal disease (OR
3.1, 95% CI 2.8-3.3). For localized comorbidities, odds of
overall PTB were highest for cervical incompetence (OR
13.9, 95% CI 12.8-15.0), fetal anomalies (OR 11.8, 95% CI
10.3-13.4), placenta previa (OR 9.4, 95% CI 8.9-10.0), and
placental abruption (OR 7.9, 95% CI 7.7-8.2).
Associations between comorbidities and clinical sub-
type of PTB depended on gestational age (Table 4). For
systemic comorbidities, associations with medically indi-
cated PTB were strongest for preeclampsia/eclampsia,
chronic hypertension and edema/renal disease, and ORs
were largest at 28-31 weeks of gestation. Associations
with PPROM also tended to be stronger at 28-31 weeks,
especially for mental disorders, genitourinary infection
and cardiovascular disease. Hypertension was not asso-
ciated with greater odds of PPROM at any gestational
age (some ORs suggested a protective association). Dia-
betes was associated with PPROM after 28 weeks
(adjusted ORs: 1.3 to 3.5), but the associations were
stronger for pre-existing than for gestational diabetes.
Drug dependence (adjusted ORs: 3.3 to 5.9), general
infection (adjusted ORs: 1.4 to 3.0), and thyroid disease
(adjusted ORs: 1.3 to 1.9) were more strongly associated
with PPROM at < 32 weeks than 32-36 weeks, while ane-
mia was associated with PPROM at < 32 weeks only
(adjusted ORs: 1.7 to 2.1). Associations with spontaneous
PTB were strongest for drug dependence and mental dis-
orders at all gestational ages, and pre-existing diabetes at
28-31 weeks. Genitourinary infection was weakly asso-
ciated with spontaneous PTB at < 28 weeks only
(adjusted OR = 1.3), while preeclampsia/eclampsia (but
not other categories of hypertension) was weakly asso-
ciated with spontaneous PTB at 32-36 weeks (adjusted
OR = 1.1). Thyroid disease was associated with sponta-
neous PTB only at 28-31 weeks, while anemia was asso-
ciated with spontaneous PTB only at < 28 weeks.
Localized comorbidities were generally associated with
medically indicated PTB and PPROM at most gestational
ages, while the associations with spontaneous PTB
tended to be stronger at < 32 weeks of gestation. Previous
cesarean delivery was associated with greater odds of
medically indicated PTB after 28 weeks, but lower odds
of PPROM at 32-36 weeks and spontaneous PTB at all
gestational ages.
Attributable fractions suggested that preeclampsia/
eclampsia, anemia, placental abruption, structural
abnormalities, and chorioamnionitis were important con-
tributors to medically indicated PTB at the population
level, though the contribution varied by gestational age
(Table 5). Anemia and genitourinary infections, as well as
placental abruption, chorioamnionitis, and structural
abnormalities, were the largest contributors to PPROM.
No particular cause of systemic comorbidity accounted
Table 3 Association between maternal systemic/localized comorbidity and preterm birth (PTB) by clinical subtype
Unadjusted OR (95% CI) Adjusted OR (95% CI)* Population attributable fraction
All PTB
Systemic comorbidity 1.67 (1.64-1.69) 1.66 (1.63-1.68) 12.8
Localized comorbidity 2.23 (2.20-2.27) 2.27 (2.24-2.31) 16.9
Medically indicated PTB
Systemic comorbidity 4.11 (4.00-4.22) 4.01 (3.90-4.11) 21.8
Localized comorbidity 4.88 (4.76-5.01) 4.83 (4.71-4.96) 23.3
PPROM
†
Systemic comorbidity 1.23 (1.19-1.26) 1.18 (1.15-1.22) 8.0
Localized comorbidity 1.85 (1.80-1.90) 1.83 (1.78-1.88) 21.1
Spontaneous PTB
‡
Systemic comorbidity 0.99 (0.97-1.02) 1.00 (0.97-1.02) 0
Localized comorbidity 1.31 (1.28-1.35) 1.38 (1.34-1.42) 5.8
* Odds ratio (OR), 95% confidence interval (CI) adjusted for maternal age, grand multiparity, and period
† Preterm premature rupture of membranes
‡ Spontaneous preterm labour before 37 weeks of gestation with intact membranes
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Page 5 of 10Table 4 Association between maternal systemic/localized comorbidity and preterm birth according to clinical subtype and gestational age*
Medically indicated PPROM
† Spontaneous
‡
< 28 wk 28-31 wk 32-36 wk < 28 wk 28-31 wk 32-36 wk < 28 wk 28-31 wk 32-36 wk
Systemic comorbidity
Hypertension
Preeclampsia/eclampsia 17.6 (15.4-20.1) 38.7 (35.6-42.1) 18.5 (17.8-19.1) 0.2 (0.1-0.5) 0.6 (0.4-0.9) 0.9 (0.8-1.0) 0.3 (0.2-0.5) 0.7 (0.5-1.1) 1.1 (1.0-1.2)
Pre-existing 3.4 (2.1-5.4) 6.7 (5.1-8.8) 5.1 (4.6-5.6) 1.3 (0.7-2.3) 1.2 (0.7-2.0) 1.1 (0.9-1.3) 1.0 (0.5-1.7) 0.9 (0.5-1.9) 0.9 (0.8-1.1)
Gestational 1.1 (0.5-2.0) 2.1 (1.4-3.1) 2.8 (2.5-3.1) 0.1 (0.0-0.6) 0.5 (0.2-0.9) 0.6 (0.5-0.7) 0.2 (0.1-0.6) 0.1 (0.0-0.5) 0.6 (0.5-0.7)
Cardiovascular disease 2.2 (1.2-4.3) 3.4 (2.3-4.9) 3.0 (2.6-3.4) 1.6 (0.8-3.4) 2.4 (1.5-4.0) 1.3 (1.0-1.6) 1.6 (0.8-2.9) 2.0 (1.1-3.7) 1.1 (0.9-1.3)
Diabetes
Pre-existing 1.2 (0.8-1.9) 3.2 (2.6-3.9) 3.9 (3.6-4.2) 1.2 (0.8-1.8) 3.5 (2.8-4.4) 2.0 (1.9-2.2) 0.9 (0.6-1.4) 2.2 (1.7-3.1) 1.4 (1.3-1.6)
Gestational 0.6 (0.4-0.8) 1.2 (1.0-1.4) 1.7 (1.6-1.8) 0.5 (0.3-0.7) 1.3 (1.0-1.6) 1.5 (1.4-1.6) 0.3 (0.2-0.4) 0.8 (0.6-1.1) 1.3 (1.3-1.4)
Edema/renal disease 6.8 (4.4-10.3) 11.9 (9.4-14.9) 7.3 (6.6-8.1) 1.4 (0.6-3.3) 1.7 (0.9-3.3) 1.1 (0.8-1.4) 1.8 (1.0-3.4) 0.9 (0.3-2.4) 1.1 (0.9-1.4)
Genitourinary infection 1.7 (1.3-2.3) 2.6 (2.2-3.1) 1.8 (1.7-1.9) 2.1 (1.6-2.7) 2.6 (2.1-3.1) 1.2 (1.1-1.3) 1.3 (1.0-1.7) 1.0 (0.7-1.4) 1.0 (0.9-1.1)
General infection 2.5 (1.8-3.5) 2.2 (1.7-2.8) 2.2 (2.0-2.4) 3.0 (2.3-4.0) 2.8 (2.2-3.6) 1.4 (1.2-1.5) 1.7 (1.3-2.4) 2.1 (1.5-2.9) 1.3 (1.2-1.4)
Thyroid disease 2.3 (1.6-3.4) 2.1 (1.6-2.8) 1.9 (1.7-2.1) 1.9 (1.3-2.9) 1.9 (1.3-2.6) 1.3 (1.2-1.5) 1.1 (0.7-1.7) 1.6 (1.0-2.5) 1.1 (1.0-1.2)
Anemia 2.2 (1.9-2.6) 2.7 (2.4-2.9) 1.6 (1.5-1.7) 2.1 (1.8-2.4) 1.7 (1.5-1.9) 0.9 (0.9-0.9) 1.3 (1.2-1.5) 1.0 (0.8-1.2) 0.7 (0.7-0.8)
Drug dependence 1.8 (0.8-4.4) 5.1 (3.5-7.5) 3.3 (2.8-3.9) 5.9 (3.7-9.3) 4.9 (3.2-7.4) 3.3 (2.8-3.9) 3.9 (2.4-6.2) 6.1 (4.0-9.2) 4.1 (3.6-4.6)
Mental disorders 3.6 (2.5-5.3) 2.6 (1.9-3.6) 2.4 (2.1-2.7) 3.3 (2.2-4.8) 4.1 (3.0-5.5) 1.9 (1.7-2.2) 2.7 (1.9-3.8) 2.6 (1.7-3.9) 1.8 (1.6-2.0)
Localized comorbidity
Hemorrhage
Placental abruption 27.7 (24.2-31.8) 25.2 (22.9-27.9) 10.7 (10.2-11.3) 24.7 (21.6-28.2) 19.7 (17.5-22.2) 3.0 (2.8-3.2) 30.4 (27.4-33.7) 28.4 (25.3-31.8) 5.1 (4.9-5.4)
Placenta previa 17.7 (12.9-24.2) 30.4 (25.6-36.1) 29.8 (27.9-31.8) 16.8 (12.5-22.7) 6.6 (4.5-9.6) 2.1 (1.8-2.5) 3.4 (2.0-5.9) 3.0 (1.5-5.7) 0.8 (0.6-1.0)
Chorioamnionitis 3.8 (3.3-4.5) 1.5 (1.3-1.8) 0.9 (0.9-1.0) 24.0 (21.5-26.8) 12.4 (11.2-13.6) 2.0 (1.9-2.1) 9.6 (8.7-10.6) 4.5 (3.9-5.2) 1.0 (1.0-1.1)
Amniotic sac
Polyhydramnios 3.1 (2.0-4.7) 5.1 (4.0-6.5) 3.6 (3.3-4.0) 1.7 (1.0-3.0) 2.4 (1.6-3.5) 1.3 (1.1-1.5) 2.1 (1.4-3.1) 4.1 (3.0-5.6) 1.6 (1.5-1.8)
Oligohydramnios 10.2 (8.4-12.4) 13.0 (11.5-14.8) 8.6 (8.1-9.1) 15.1 (12.8-17.8) 12.6 (10.9-14.6) 2.2 (2.0-2.4) 2.6 (2.0-3.5) 1.7 (1.1-2.5) 0.8 (0.7-0.9)
Cervical incompetence 68.6 (54.6-86.1) 13.6 (9.8-18.9) 7.1 (6.1-8.4) 123 (103-146) 33.4 (26.1-42.7) 6.1 (5.1-7.2) 159 (139-183) 32.4 (24.5-42.9) 6.9 (5.9-7.9)
Structural abnormality 6.8 (5.5-8.3) 6.3 (5.4-7.3) 3.5 (3.2-3.7) 4.2 (3.3-5.2) 4.2 (3.4-5.1) 2.0 (1.9-2.2) 2.5 (2.0-3.2) 2.2 (1.6-2.9) 0.8 (0.7-0.9)
Previous cesarean delivery 1.2 (1.0-1.4) 1.3 (1.1-1.4) 2.0 (2.0-2.1) 1.1 (0.9-1.3) 0.9 (0.7-1.0) 0.8 (0.7-0.8) 0.4 (0.3-0.5) 0.5 (0.4-0.6) 0.4 (0.4-0.4)
Fetal anomaly 159 (123-204) 16.3 (10.2-26.2) 12.4 (10.1-15.3) 3.2 (0.8-12.8) 7.0 (3.1-15.6) 2.3 (1.5-3.5) 142 (115-176) 8.7 (3.9-19.6) 4.1 (3.1-5.5)
* Odds ratio (95% confidence interval) adjusted for maternal age, grand multiparity, and period (rounded to the first decimal to conserve space)
† Preterm premature rupture of membranes
‡ Spontaneous preterm labour before 37 weeks of gestation with intact membranes
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0for a substantial fraction of spontaneous PTB, but major
localized morbidities including placental abruption, chor-
ioamnionitis, cervical incompetence and structural
abnormalities were important contributors, especially at
< 32 weeks of gestation.
Discussion
To our knowledge, this study is the first to evaluate rela-
tions between systemic and localized maternal comorbid-
ities with PTB by clinical subtype and gestational age. In
a large population-based cohort, we demonstrated that
comorbidities overall were associated with higher likeli-
hoods of medically indicated PTB, while only comorbid-
ities localized to the reproductive tract were associated
with spontaneous PTB. At the population level, several
major localized comorbidities (placental abruption, chor-
ioamnionitis, oliogohydramnios, structural abnormality,
cervical incompetence) were key contributors to all three
clinical subtypes of PTB, especially at < 32 weeks of
gestation. In contrast, major systemic comorbidities (pre-
eclampsia, anemia) were the key contributors to medi-
cally indicated PTBs, but not spontaneous PTBs. This
study is the first to identify anemia as the most important
maternal systemic comorbidity contributing to PPROM
at the population level.
Hypertension is a major pregnancy complication [26].
We found that preeclampsia/eclampsia was strongly asso-
ciated with medically indicated PTB, confirming the find-
ings from other studies [1,4,27-30]. Data are conflicting as
to whether hypertension may be a stronger determinant of
early than of late PTB, but previous studies are limited as
they often do not differentiate clinical subtypes of PTB
[6,31]. We observed that preeclampsia/eclampsia and pre-
existing hypertension were strongly associated with medi-
cally indicated PTB at all gestational ages. This was not
the case for gestational and unspecified hypertension that
Table 5 Population attributable fractions for maternal systemic/localized comorbidity and preterm birth according to
clinical subtype and gestational age*
Medically indicated PPROM* Spontaneous
†
< 28 wk 28-31 wk 32-36 wk < 28 wk 28-31 wk 32-36 wk < 28 wk 28-31 wk 32-36 wk
Systemic comorbidity
Hypertension
Preeclampsia/eclampsia 21.6 38.0 21.9 -1.2 -0.7 -0.2 -1.2 -0.6 0.2
Pre-existing 0.8 1.1 1.6 0 0.1 0.1 0 0 -0.1
Gestational 0.2 1.8 1.8 -4.5 -0.8 -0.4 -2.4 -4.3 -0.3
Cardiovascular disease 0.4 0.8 0.6 0.1 0.5 0.1 0.2 0.3 0.02
Diabetes
Pre-existing 0.3 2.7 3.4 0.1 3.0 1.2 -0.1 1.4 0.5
Gestational -1.9 0.6 2.6 -1.5 1.0 1.8 -3.0 -0.8 1.1
Edema/renal disease 1.6 2.9 1.7 0.1 0.2 0.02 0.2 -0.03 0.03
Genitourinary infection 1.7 3.7 1.9 1.7 3.6 0.5 0.7 -0.02 -0.05
General infection 1.8 1.4 1.4 1.6 2.1 0.4 0.9 1.2 0.3
Thyroid disease 1.4 1.0 0.9 0.6 0.8 0.3 0.1 0.5 0.1
Anemia 11.9 14.8 5.9 6.7 6.6 -1.1 3.3 -0.1 -2.9
Drug dependence 0.03 0.9 0.5 0.8 0.9 0.5 0.7 1.1 0.7
Mental disorders 1.7 0.9 0.8 0.9 1.8 0.5 1.0 0.8 0.4
Localized comorbidity
Hemorrhage
Placental abruption 23.5 21.0 9.8 14.1 17.9 2.4 25.2 22.9 4.5
Placenta previa 3.3 5.9 6.6 2.2 1.2 0.3 0.5 0.4 -0.1
Chorioamnionitis 10.5 2.0 -0.3 31.4 30.7 3.8 25.1 11.7 0.04
Amniotic sac
Polyhydramnios 1.3 2.3 1.5 0.3 0.8 0.2 0.7 1.8 0.4
Oligohydramnios 8.7 10.3 7.0 8.2 10.2 1.2 1.6 0.6 -0.2
Cervical incompetence 7.2 1.4 0.7 8.1 3.5 0.5 14.6 3.1 0.6
Structural abnormality 41.9 36.0 17.3 14.9 22.9 7.0 11.8 6.2 -1.2
Previous cesarean delivery 1.4 2.3 8.7 0.4 -1.3 -2.3 -5.7 -4.7 -5.4
Fetal anomaly 6.5 0.7 0.5 0.1 0.3 0.1 5.7 0.3 0.1
* Preterm premature rupture of membranes
† Spontaneous preterm labour before 37 gestational weeks with intact membranes
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weeks, albeit much more weakly. Few studies have evalu-
ated the link between hypertension and spontaneous PTB.
Two studies found that pre-existing and gestational hyper-
tension in the US were associated with more than 60%
greater odds of spontaneous PTB, but PPROM was not
evaluated [29,32]. In contrast, we found that hypertension
was not associated with elevated odds of either PPROM or
spontaneous PTB. In fact, ORs were protective for some
hypertensive disorders. Close monitoring of hypertensive
pregnancies may partly explain the protective associations
with PPROM and spontaneous PTB, via shifting of poten-
tial PTBs to the medically indicated subtype (through
early detection and labour induction).
The influence of diabetes, another common pregnancy
complication, also depended on clinical subtype of PTB
and gestational age. We confirmed that compared to
gestational diabetes, pre-existing diabetes was more
strongly associated with medically indicated PTB [18,33].
Diabetes was associated with greater odds of PPROM
after 28 weeks, but the magnitude was also greater for
pre-existing than for gestational diabetes. A strong asso-
ciation with spontaneous PTB at 28-31 weeks was only
observed for pre-existing diabetes. Other research also
suggests strong associations between pre-existing dia-
betes and spontaneous PTB [18,29,33]. One study evalu-
ating the odds of very PTB (< 32 weeks) found strong
associations with pre-existing type 1 diabetes, but the
clinical subtype of PTB was not differentiated [34].
Drug dependence and mental disorders are increasingly
recognized as drivers of PTB [35-37]. We observed that
drug dependence and mental disorders were associated
with all clinical subtypes of PTB at most gestational ages.
This finding is novel and important because most studies
have focused on infections as a cause of PPROM and
spontaneous PTB, while other comorbidities have been
less studied [1,8,38]. Psychological or social stress, psychia-
tric disorders, and substance abuse have been associated
with overall PTB [1,5,37,39], while other research has
demonstrated associations between depression and medi-
cally indicated PTB at < 35 weeks [40], and between anxi-
ety/alcohol use and spontaneous PTB [41]. Our findings
confirm an association between infections and all PTB
clinical subtypes at all gestational ages [1,8,10,11,32,42].
Prevention of PTB would likely benefit from greater atten-
tion to drug dependence and mental disorders given the
probable underreporting of these causes in pregnancy
(with consequently underestimated attributable fractions)
[35,36], since the benefits of treatment for infection are
uncertain [7,43,44].
Remaining causes of systemic comorbidity including
cardiovascular disease, edema/renal disease, thyroid dis-
ease, and anemia were mainly associated with medically
indicated PTB at all gestational ages, as observed
elsewhere [4,18,30]. Thyroid disease and anemia, how-
ever, were mainly associated with PPROM at earlier
gestational ages (< 32 weeks). For spontaneous PTB,
associations were strong with cardiovascular disease at
28-31 weeks, and weak with thyroid disease at 28-31
weeks and anemia at < 28 weeks. Anemia has been asso-
ciated with greater odds of spontaneous PTB but not
PPROM and medically indicated PTB [45]. Other
researchers have observed that thyroid disorders were
only associated with PPROM [18], whereas we found that
thyroid disorders were also associated with medically
indicated and spontaneous PTBs at 28-31 weeks. More
research is needed to better understand the relation
between these maternal comorbidities and PTB, espe-
cially anemia which was associated with large attributable
fractions for PPROM and medically indicated PTB.
Localized comorbidities in general were associated with
PTB, especially medically indicated PTB and PPROM at
most gestational ages. Several studies have found that
overall PTB was associated with cervical incompetence,
fetal anomalies, placenta previa, placental abruption, and
oligohydramnios [1,4,5,17], and fewer have, like ours,
demonstrated stronger associations at lower gestational
ages for placental abruption, chorioamnionitis, oligohy-
dramnios, cervical incompetence, and fetal factors
[5,6,15,46]. Spontaneous PTB has been linked with pla-
centa previa and abruption, while polyhydramnios/oligo-
hydramnios were associated with both PPROM and
spontaneous PTB [1,14,42]. Interestingly, we found that
previous cesarean delivery was associated with lower odds
of PPROM and spontaneous PTB.
This study was subject to limitations. Some comorbid-
ities could not be examined in finer categories due to
limited ICD code availability or sample size (e.g., cardio-
vascular and thyroid disease), and underreporting of cer-
tain comorbidities (e.g., drug dependence and mental
disorders) is probable. Though hospital data are routinely
used for surveillance in Québec [16], validation of diag-
nostic (or procedure) codes has not been undertaken,
and results should be interpreted in light of probable
non-differential misclassification which may have attenu-
ated associations. Though spontaneous PTBs that
resulted in cesarean deliveries could not be identified and
were classified as medically indicated, our results are con-
sistent with other studies indicating greater frequencies
of spontaneous PTB compared with other clinical sub-
types [1,9,17], which suggests that misclassifications are
relatively infrequent. We did not have detailed data
on parity or other individual maternal characteristics
such as income, race, smoking, genetics, or infertility
treatment that are known to be associated with PTB.
These characteristics have complex relationships
with PTB [1,13,47-53], and may be upstream risk factors
influencing PTB at least partly through maternal
Auger et al. BMC Pregnancy and Childbirth 2011, 11:67
http://www.biomedcentral.com/1471-2393/11/67
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without public health insurance is unclear.
Conclusions
This study demonstrated that the associations between
maternal comorbidities and PTB may differ by clinical
subtype and gestational age. Preventive strategies to
reduce PTB should target major systemic and localized
co-morbidities that account for large proportions of PTBs,
especially maternal hypertension, anemia, placental abrup-
tion, and structural abnormalities. Better clinical manage-
ment of these maternal comorbidities may be helpful, but
such measures should take into account variation in asso-
ciations by clinical subtype and gestational age.
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Additional file 1: Definition of systemic and localized maternal
comorbidity based on International Classification of Diseases (ICD)-
9 codes. International Classification of Disease codes (ninth revision) for
the causes of maternal comorbidity analyzed in the current study.
Acknowledgements
This work was supported by the Canadian Institutes for Health Research,
Institute of Human Development, Child and Youth Health (CIHR grant
#225924). TUNL was supported by the Programme canadien de bourses de
la Francophonie (PCBF). The funding sources were not involved in the study
design, interpretation of results, manuscript preparation, or the decision to
submit the article for publication.
Author details
1Institut national de santé publique du Québec, 190, boulevard Crémazie Est,
Montréal, Québec, H2P-1E2, Canada.
2Research Centre of the University of
Montréal Hospital Centre, 3875 rue Saint-Urbain, Montréal, Québec, H2W-
1V1, Canada.
3Department of Social and Preventive Medicine, University of
Montréal, C.P. 6128, succursale Centre-ville, Montréal, Québec, H3C-3J7,
Canada.
4Department of Obstetrics and Gynecology, CHU Sainte Justine,
University of Montréal, 3175 Cote-Sainte-Catherine, Montréal, Canada.
Authors’ contributions
NA and TUNL conceived the study, with contributions from ZCL. NA
prepared the data. TUNL/ALP performed the statistical analyses. NA and
TUNL interpreted the results with contributions from ALP and ZCL. NA and
TUNL reviewed the literature and wrote the manuscript. ALP and ZCL
critically revised the manuscript for scientific quality and content. All authors
approved the final version for publication.
Competing interests
The authors declare that they have no competing interests.
Received: 7 April 2011 Accepted: 4 October 2011
Published: 4 October 2011
References
1. Goldenberg RL, Culhane JF, Iams JD, Romero R: Epidemiology and causes
of preterm birth. Lancet 2008, 371:75-84.
2. Kramer MS, Demissie K, Yang H, Platt RW, Sauve R, Liston R: The
contribution of mild and moderate preterm birth to infant mortality.
Fetal and Infant Health Study Group of the Canadian Perinatal
Surveillance System. JAMA 2000, 284:843-849.
3. Saigal S, Doyle LW: An overview of mortality and sequelae of preterm
birth from infancy to adulthood. Lancet 2008, 371:261-269.
4. Ananth CV, Vintzileos AM: Maternal-fetal conditions necessitating a
medical intervention resulting in preterm birth. Am J Obstet Gynecol 2006,
195:1557-1563.
5. Ofori BD, Le Tiec M, Berard A: Risk factors associated with preterm birth
according to gestational age at birth. Pharmacoepidemiol Drug Saf 2008,
17:556-564.
6. Martius JA, Steck T, Oehler MK, Wulf KH: Risk factors associated with
preterm (< 37+0 weeks) and early preterm birth (< 32+0 weeks):
univariate and multivariate analysis of 106 345 singleton births from the
1994 statewide perinatal survey of Bavaria. Eur J Obstet Gynecol Reprod
Biol 1998, 80:183-189.
7. Iams JD, Romero R, Culhane JF, Goldenberg RL: Primary, secondary, and
tertiary interventions to reduce the morbidity and mortality of preterm
birth. Lancet 2008, 371:164-175.
8. Muglia LJ, Katz M: The enigma of spontaneous preterm birth. N Engl J
Med 2010, 362:529-535.
9. Ananth CV, Vintzileos AM: Epidemiology of preterm birth and its clinical
subtypes. J Matern Fetal Neonatal Med 2006, 19:773-782.
10. Andrews WW, Goldenberg RL, Mercer B, Iams J, Meis P, Moawad A, Das A,
VanDorsten JP, Caritis SN, Thurnau G, Miodovnik M, Roberts J, McNellis D:
The Preterm Prediction Study: association of second-trimester
genitourinary chlamydia infection with subsequent spontaneous
preterm birth. Am J Obstet Gynecol 2000, 183:662-668.
11. Andrews WW, Hauth JC, Goldenberg RL: Infection and preterm birth. Am J
Perinatol 2000, 17:357-365.
12. Morin I, Morin L, Zhang X, Platt RW, Blondel B, Breart G, Usher R,
Kramer MS: Determinants and consequences of discrepancies in
menstrual and ultrasonographic gestational age estimates. BJOG 2005,
112:145-152.
13. Auger N, Roncarolo F, Harper S: Increasing educational inequality in
preterm birth in Quebec, Canada, 1981-2006. J Epidemiol Community
Health 2010, published online.
14. Lo CC, Hsu JJ, Hsieh CC, Hsieh TT, Hung TH: Risk factors for spontaneous
preterm delivery before 34 weeks of gestation among Taiwanese
women. Taiwan J Obstet Gynecol 2007, 46:389-394.
15. McElrath TF, Hecht JL, Dammann O, Boggess K, Onderdonk A,
Markenson G, Harper M, Delpapa E, Allred EN, Leviton A: Pregnancy
disorders that lead to delivery before the 28th week of gestation: an
epidemiologic approach to classification. Am J Epidemiol 2008,
168:980-989.
16. Institut national de santé publique du Québec et ministère de la Santé et
Services sociaux du Québec: Portrait de santé du Québec et de ses
régions 2006: les statistiques - Deuxième rapport national sur l’état de
santé de la population du Québec. Gouvernement du Québec; 2006
[http://www.inspq.qc.ca/pdf/publications/portrait_de_sante.asp?E=p].
17. Moutquin JM: Classification and heterogeneity of preterm birth. BJOG
2003, 110(Suppl 20):30-33.
18. Berkowitz GS, Blackmore-Prince C, Lapinski RH, Savitz DA: Risk factors for
preterm birth subtypes. Epidemiology 1998, 9:279-285.
19. Ip M, Peyman E, Lohsoonthorn V, Williams MA: A case-control study of
preterm delivery risk factors according to clinical subtypes and severity.
J Obstet Gynaecol Res 2010, 36:34-44.
20. International Classification of Diseases, ninth revision. [http://icd9cm.
chrisendres.com/index.php?action=contents], (accessed 25 July 2011).
21. Simonsen SM, Lyon JL, Alder SC, Varner MW: Effect of grand multiparity
on intrapartum and newborn complications in young women. Obstet
Gynecol 2005, 106:454-460.
22. Agresti A: Categorical Data Analysis New York: Wiley-Interscience; 2002, 267.
23. Statistical Computing Seminar: Proc Logistic and Logistic Regression
Models. UCLA: Academic Technology Services, Statistical Consulting Group;
[http://www.ats.ucla.edu/stat/sas/seminars/sas_logistic/logistic1.htm],
(accessed 26 July 2011).
24. Hanley JA: A heuristic approach to the formulas for population
attributable fraction. J Epidemiol Community Health 2001, 55:508-514.
25. Zhang J, Yu KF: What’s the relative risk? A method of correcting the
odds ratio in cohort studies of common outcomes. JAMA 1998,
280:1690-1691.
26. Sibai B, Dekker G, Kupferminc M: Pre-eclampsia. Lancet 2005, 365:785-799.
27. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD,
Klebanoff M, Vandorsten P, Landon M, Paul R, Miodovnik M, Meis P,
Thurnau G: Adverse perinatal outcomes are significantly higher in severe
Auger et al. BMC Pregnancy and Childbirth 2011, 11:67
http://www.biomedcentral.com/1471-2393/11/67
Page 9 of 10gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol
2002, 186:66-71.
28. Kurkinen-Raty M, Koivisto M, Jouppila P: Preterm delivery for maternal or
fetal indications: maternal morbidity, neonatal outcome and late
sequelae in infants. BJOG 2000, 107:648-655.
29. Sibai BM, Caritis SN, Hauth JC, Macpherson C, VanDorsten JP, Klebanoff M,
Landon M, Paul RH, Meis PJ, Miodovnik M, Dombrowski MP, Thurnau GR,
Moawad AH, Roberts J: Preterm delivery in women with pregestational
diabetes mellitus or chronic hypertension relative to women with
uncomplicated pregnancies. The National institute of Child health and
Human Development Maternal- Fetal Medicine Units Network. Am J
Obstet Gynecol 2000, 183:1520-1524.
30. Ananth CV, Vintzileos AM: Medically indicated preterm birth: recognizing
the importance of the problem. Clin Perinatol 2008, 35:53-67.
31. Catov JM, Wu CS, Olsen J, Sutton-Tyrrell K, Li J, Nohr EA: Early or recurrent
preterm birth and maternal cardiovascular disease risk. Ann Epidemiol
2010, 20:604-609.
32. Samadi AR, Mayberry RM: Maternal hypertension and spontaneous
preterm births among black women. Obstet Gynecol 1998, 91:899-904.
33. Kock K, Kock F, Klein K, Bancher-Todesca D, Helmer H: Diabetes mellitus
and the risk of preterm birth with regard to the risk of spontaneous
preterm birth. J Matern Fetal Neonatal Med 2010, 23:1004-1008.
34. Persson M, Norman M, Hanson U: Obstetric and perinatal outcomes in
type 1 diabetic pregnancies: A large, population-based study. Diabetes
Care 2009, 32:2005-2009.
35. Keegan J, Parva M, Finnegan M, Gerson A, Belden M: Addiction in
pregnancy. J Addict Dis 2010, 29:175-191.
36. Rehm J, Baliunas D, Borges GL, Graham K, Irving H, Kehoe T, Parry CD,
Patra J, Popova S, Poznyak V, Roerecke M, Room R, Samokhvalov AV,
Taylor B: The relation between different dimensions of alcohol
consumption and burden of disease: an overview. Addiction 2010,
105:817-843.
37. Lee HC, Lin HC: Maternal bipolar disorder increased low birthweight and
preterm births: a nationwide population-based study. J Affect Disord
2010, 121:100-105.
38. Goldenberg RL, Hauth JC, Andrews WW: Intrauterine infection and
preterm delivery. N Engl J Med 2000, 342:1500-1507.
39. Pinto SM, Dodd S, Walkinshaw SA, Siney C, Kakkar P, Mousa HA: Substance
abuse during pregnancy: effect on pregnancy outcomes. Eur J Obstet
Gynecol Reprod Biol 2010, 150:137-141.
40. Gavin AR, Holzman C, Siefert K, Tian Y: Maternal depressive symptoms,
depression, and psychiatric medication use in relation to risk of preterm
delivery. Womens Health Issues 2009, 19:325-334.
41. Orr ST, Reiter JP, Blazer DG, James SA: Maternal prenatal pregnancy-
related anxiety and spontaneous preterm birth in Baltimore, Maryland.
Psychosom Med 2007, 69:566-570.
42. Furman B, Shoham-Vardi I, Bashiri A, Erez O, Mazor M: Clinical significance
and outcome of preterm prelabor rupture of membranes: population-
based study. Eur J Obstet Gynecol Reprod Biol 2000, 92:209-216.
43. Shennan AH, Chandiramani M: Antibiotics for spontaneous preterm birth.
BMJ 2008, 337:a3015.
44. Vrachnis N, Vitoratos N, Iliodromiti Z, Sifakis S, Deligeoroglou E, Creatsas G:
Intrauterine inflammation and preterm delivery. Ann N Y Acad Sci 2010,
1205:118-122.
45. Zhang Q, Ananth CV, Li Z, Smulian JC: Maternal anaemia and preterm
birth: a prospective cohort study. Int J Epidemiol 2009, 38:1380-1389.
46. Iams JD, Johnson FF, Sonek J, Sachs L, Gebauer C, Samuels P: Cervical
competence as a continuum: a study of ultrasonographic cervical length
and obstetric performance. Am J Obstet Gynecol 1995, 172:1097-1103.
47. Smith LK, Draper ES, Manktelow BN, Dorling JS, Field DJ: Socioeconomic
inequalities in very preterm birth rates. Arch Dis Child Fetal Neonatal Ed
2007, 92:F11-F14.
48. Messer LC, Kaufman JS, Mendola P, Laraia BA: Black-white preterm birth
disparity: a marker of inequality. Ann Epidemiol 2008, 18(11):851-858.
49. Reagan PB, Salsberry PJ: Race and ethnic differences in determinants of
preterm birth in the USA: broadening the social context. Soc Sci Med
2005, 60:2217-2228.
50. Aliyu MH, Lynch O, Saidu R, Alio AP, Marty PJ, Salihu HM: Intrauterine
exposure to tobacco and risk of medically indicated and spontaneous
preterm birth. Am J Perinatol 2010, 27:405-410.
51. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A: Preterm
birth and low birth weight among in vitro fertilization singletons: a
systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol
2009, 146(2):138-148.
52. D’Angelo DV, Whitehead N, Helms K, Barfield W, Ahluwalia IB: Birth
outcomes of intended pregnancies among women who used assisted
reproductive technology, ovulation stimulation, or no treatment. Fertil
Steril 2011, 96:314-320.
53. Miranda ML, Maxson P, Edwards S: Environmental contributions to
disparities in pregnancy outcomes. Epidemiol Rev 2009, 31:67-83.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2393/11/67/prepub
doi:10.1186/1471-2393-11-67
Cite this article as: Auger et al.: Association between maternal
comorbidity and preterm birth by severity and clinical subtype:
retrospective cohort study. BMC Pregnancy and Childbirth 2011 11:67.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Auger et al. BMC Pregnancy and Childbirth 2011, 11:67
http://www.biomedcentral.com/1471-2393/11/67
Page 10 of 10